CANNAPHARMARX, INC. Derivative Liability, Current
CANNAPHARMARX, INC. (CPMD) had Derivative Liability, Current of $2.81 million as of 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-08-18
- 2026-06-30: Derivative Liability, Current $2.81M.
- 2026-03-31: Derivative Liability, Current $1.21M.
- 2025-12-31: Derivative Liability, Current $2.01M.
- 2025-09-30: Derivative Liability, Current $556.75K.
| Period end | Derivative Liability, Current |
|---|---|
| 2026-06-30 | $2.81M 10-Q · filed 2026-08-18 |
| 2026-03-31 | $1.21M 10-Q · filed 2026-05-20 |
| 2025-12-31 | $2.01M 10-Q · filed 2026-08-18 |
| 2025-09-30 | $556.75K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $564.05K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $517.61K 10-Q · filed 2025-05-16 |
| 2024-12-31 | $1.16M 10-Q · filed 2026-08-18 |
| 2024-09-30 | $651.51K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $645.30K 10-Q · filed 2024-11-14 |
| 2024-03-31 | $9.30M 10-Q · filed 2024-06-25 |
| 2023-12-31 | $1.26M 10-K · filed 2026-03-31 |
| 2023-09-30 | $906.95K 10-Q · filed 2023-11-17 |
| 2023-06-30 | $1.36M 10-Q · filed 2023-10-13 |
| 2023-03-31 | $772.61K 10-Q · filed 2023-09-22 |
| 2022-12-31 | $1.01M 10-Q · filed 2024-11-14 |
| 2022-09-30 | $1.23M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $1.15M 10-Q · filed 2022-08-22 |
| 2022-03-31 | $1.09M 10-Q · filed 2022-05-23 |
| 2021-12-31 | $507.49K 10-K · filed 2023-09-01 |
| 2021-09-30 | $982.43K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $598.68K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.05M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $3.68M 10-K · filed 2022-04-15 |
| 2020-09-30 | $1.75M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $969.10K 10-Q · filed 2020-08-19 |
| 2020-03-31 | $925.48K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $0.00 10-K · filed 2021-04-14 |